Dr Rakesh Parbhu, MD | |
3501 Johnson Street, Pembroke Pines, FL 33021 | |
(954) 437-4800 | |
(954) 437-6628 |
Full Name | Dr Rakesh Parbhu |
---|---|
Gender | Male |
Speciality | Diagnostic Radiology |
Experience | 26 Years |
Location | 3501 Johnson Street, Pembroke Pines, Florida |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1659584548 | NPI | - | NPPES |
90612 | Other | FL | BCBS |
000708400 | Medicaid | FL |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2085R0202X | Radiology - Diagnostic Radiology | 39916 (Tennessee) | Secondary |
2085R0202X | Radiology - Diagnostic Radiology | ME100962 (Florida) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Memorial Regional Hospital | Hollywood, FL | Hospital |
Memorial Hospital West | Pembroke pines, FL | Hospital |
Memorial Hospital Miramar | Miramar, FL | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Radiology Associates Of Hollywood Inc | 8628978137 | 71 |
News Archive
Sanofi Pasteur, the vaccines division of Sanofi, announced today that the U.S. Food and Drug Administration (FDA) has expanded the approved age indication of Adacel® (Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed; Tdap) for active booster immunization for the prevention of tetanus, diphtheria, and pertussis as a single dose in persons 10 through 64 years of age.
The Journal of the American Geriatrics Society (JAGS) this week rushed to publication a special article describing critical points for combatting the coronavirus disease (COVID-19) pandemic for older adults and those in long-term care.
Adaptimmune Therapeutics plc, a clinical stage biopharmaceutical company focused on the use of T-cell therapy to treat cancer, today announced that the first patient has been dosed in its expanded Phase I/II trial of its affinity enhanced T-cell receptor therapeutic targeting the NY-ESO-1 cancer antigen in synovial sarcoma patients.
Young African-Americans often hold a distorted view of their personal risk for a stroke, two nursing researchers at Georgia State University's Byrdine F. Lewis School of Nursing and Health Professions say in a recently published study in the Journal of Neuroscience Nursing.
› Verified 6 days ago
Entity Name | Radiology Associates Of Hollywood Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1659319671 PECOS PAC ID: 8628978137 Enrollment ID: O20040112000088 |
News Archive
Sanofi Pasteur, the vaccines division of Sanofi, announced today that the U.S. Food and Drug Administration (FDA) has expanded the approved age indication of Adacel® (Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed; Tdap) for active booster immunization for the prevention of tetanus, diphtheria, and pertussis as a single dose in persons 10 through 64 years of age.
The Journal of the American Geriatrics Society (JAGS) this week rushed to publication a special article describing critical points for combatting the coronavirus disease (COVID-19) pandemic for older adults and those in long-term care.
Adaptimmune Therapeutics plc, a clinical stage biopharmaceutical company focused on the use of T-cell therapy to treat cancer, today announced that the first patient has been dosed in its expanded Phase I/II trial of its affinity enhanced T-cell receptor therapeutic targeting the NY-ESO-1 cancer antigen in synovial sarcoma patients.
Young African-Americans often hold a distorted view of their personal risk for a stroke, two nursing researchers at Georgia State University's Byrdine F. Lewis School of Nursing and Health Professions say in a recently published study in the Journal of Neuroscience Nursing.
› Verified 6 days ago
Entity Name | Jupiter Imaging Associates Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1932156767 PECOS PAC ID: 5294629135 Enrollment ID: O20040211000512 |
News Archive
Sanofi Pasteur, the vaccines division of Sanofi, announced today that the U.S. Food and Drug Administration (FDA) has expanded the approved age indication of Adacel® (Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed; Tdap) for active booster immunization for the prevention of tetanus, diphtheria, and pertussis as a single dose in persons 10 through 64 years of age.
The Journal of the American Geriatrics Society (JAGS) this week rushed to publication a special article describing critical points for combatting the coronavirus disease (COVID-19) pandemic for older adults and those in long-term care.
Adaptimmune Therapeutics plc, a clinical stage biopharmaceutical company focused on the use of T-cell therapy to treat cancer, today announced that the first patient has been dosed in its expanded Phase I/II trial of its affinity enhanced T-cell receptor therapeutic targeting the NY-ESO-1 cancer antigen in synovial sarcoma patients.
Young African-Americans often hold a distorted view of their personal risk for a stroke, two nursing researchers at Georgia State University's Byrdine F. Lewis School of Nursing and Health Professions say in a recently published study in the Journal of Neuroscience Nursing.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Rakesh Parbhu, MD 500 N Hiatus Rd Ste 200, Pembroke Pines, FL 33026-5213 Ph: (954) 437-4800 | Dr Rakesh Parbhu, MD 3501 Johnson Street, Pembroke Pines, FL 33021 Ph: (954) 437-4800 |
News Archive
Sanofi Pasteur, the vaccines division of Sanofi, announced today that the U.S. Food and Drug Administration (FDA) has expanded the approved age indication of Adacel® (Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed; Tdap) for active booster immunization for the prevention of tetanus, diphtheria, and pertussis as a single dose in persons 10 through 64 years of age.
The Journal of the American Geriatrics Society (JAGS) this week rushed to publication a special article describing critical points for combatting the coronavirus disease (COVID-19) pandemic for older adults and those in long-term care.
Adaptimmune Therapeutics plc, a clinical stage biopharmaceutical company focused on the use of T-cell therapy to treat cancer, today announced that the first patient has been dosed in its expanded Phase I/II trial of its affinity enhanced T-cell receptor therapeutic targeting the NY-ESO-1 cancer antigen in synovial sarcoma patients.
Young African-Americans often hold a distorted view of their personal risk for a stroke, two nursing researchers at Georgia State University's Byrdine F. Lewis School of Nursing and Health Professions say in a recently published study in the Journal of Neuroscience Nursing.
› Verified 6 days ago
Geetika Arora Klevos, M.D Radiology Medicare: Accepting Medicare Assignments Practice Location: 15735 Pines Blvd, Pembroke Pines, FL 33027 Phone: 954-517-1725 Fax: 954-517-1729 | |
Kyungmin Kang, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 500 N Hiatus Rd Ste 200, Pembroke Pines, FL 33026 Phone: 954-437-4800 Fax: 954-437-6628 | |
Dr. Howard T. Heller, MD Radiology Medicare: Medicare Enrolled Practice Location: 9050 Pines Blvd Ste 200, Pembroke Pines, FL 33024 Phone: 954-437-4800 Fax: 954-437-6628 | |
Elitsa Ivanova, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: Memorial Hospital West, 703 North Flamingo Road, Pembroke Pines, FL 33028 Phone: 954-844-7315 | |
Dr. Srinath Sundararaman, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 500 N Hiatus Rd Ste 200, Pembroke Pines, FL 33026 Phone: 954-437-4800 | |
Matthew L Hoffman, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: Memorial Regional Pembroke, 7800 Sheridan Street, Pembroke Pines, FL 33024 Phone: 954-967-2051 | |
Dr. Hugh M Eisen, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 15811 Sw 14th St, Pembroke Pines, FL 33027 Phone: 954-435-1730 |